维普中文期刊产品整合服务
71篇 您的检索式:作者名="SCHIFF MH"
    题名 作者 年代 出处 被引量
1Interferon alfa2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C显示文摘McHutchison JG Gordon SC Schiff ER Shiffrnan ML Lee WM Rustgi VK Goodman ZD Ling MH Cort S Albrecht JK 0,,:1
2Efficacy and safetyof adalimumab in patients with ankylosing spondylitis : results of amulticenter,randomized,double-blind,placebo-controlled trial显示文摘van der Heijde D Kivitz A Schiff MH 2006Arthritis Rheum2006,54,7:1
3Adalimumab,a fully human anti-tumor necrosis factor-alpha monoclonal antibody,and concomitant standard anti-rheumatic therapy for the treatment of rheumatoid arthritis :results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis )显示文摘 Schiff MH Fleischmann RM 2003J Rheumatol2003,30,:1
4Adalimumab, a fully human anti tumor necrosis factor-α monoclonal antibody, and concomitant standard antirheumatic therpy for the treatment of rheumatoid arthritis: results of STAR ( Safety Trial of Adalimumab in Rheumatoid Arthritis) 显示文摘Furst DE Schiff MH Fleischmann RM 2003J Rheumatol2003,30,12:1
5Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis 显示文摘Schiff MH 2000Ann Rheum Dis2000,59,1:1
6Head-to-head? randomised,crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis:drug-exposure limitations of oral methotrexate at doses -15 mg may be overcome with subcutaneous administration显示文摘Schiff MH Jaffe JS Freundlich B 2014Ann Rheum Dis2014,73,8:1
7A simplified disease activity index h~r rheumatoid arthritis for use in clinical practice 显示文摘Smolen JS Breedveld FC Schiff MH 2003Rheumatology ( Oxford)2003,42,:1
8Safety of extended treatment with anakinra in patients with rheumatoid arthritis显示文摘Fleischmann RM Tesser J Schiff MH 0,,08:1
9Renal toxicity asso- with drugs rheumatoid disease-modifying antirheu- used for the treatment of arthritis 显示文摘Schiff ciated matic MH Whelton A 2000Semin hrthri- tis Rheum2000,30,3:1
10Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial 显示文摘VAN DER HEIJDE D KIVITZ A SCHIFF MH 2006Arthritis Rheum2006,54,7:1
11Etanercept therapy in rheumatoid arthritis显示文摘Moreland LW Schiff MH 1999A randomized controlled trial Ann Intern Med1999,130,6:1
12Safety analyses of adalimumab (HUMIRA(r)) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthri-tis显示文摘Schiff MH Burmester GR Kent JM 2006Ann Rheum Dis2006,13,:1
13Renal toxicity associated with disease modifying antirheumatic drugs used for the treatmeut of rheumatoid arthiritis 显示文摘Schiff MH Whehon A 2000Semiu Arthritis Rheum2000,30,:1
14Etanercept therapy in rheumatoid arthritis显示文摘Moreland LW Schiff MH Baumgartner SW 1999Ann Intern Med1999,130,6:1
15Treatment of rheumatoid arthritis with the recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein显示文摘Morland LW Baumgartner SW Schiff MH 1997New Engl J Med1997,337,3:1
16Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein显示文摘Moreland LW Baumgarmer SW Schiff MH 1997New Engl J Med1997,337,:1
17Treatment of rheumatoid arthritis with a recombinant human TNF receptor (p75)-Fc fusion protein显示文摘 Baumgartner SW Schiff MH 1997N Engl J Med1997,337,3:1
18Safety analyses of adahmumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis 显示文摘SCHIFF MH BURMESTER GR KENT JD 2006Ann Rheum Dis2006,65,7:1
19Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein显示文摘Moreland LW Baumgartner SW Schiff MH 1997New Engl J Med1997,337,:1
20A simplified disease activity index for rheumatoid arthritis for use in clinical practice显示文摘Smolen JS Breedveld FC Schiff MH 2003Rheumatology(Oxford)2003,42,8:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费